Having trouble viewing this email? View in a browser.

You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.

Dermatology Times eNews

Dermatology Times eNews

DermatologyTimes.com

December 7, 2011

ECZEMA

Swedish study: Peptides kill stubborn Malassezia

Stockholm — New research suggests that certain peptides kill the yeast Malassezia sympodialis, a main culprit in triggering atopic and seborrheic eczema and dandruff, without harming healthy skin cells. » More

MELANOMA

New stain test can identify cancerous moles

New York — Researchers at Weill Cornell Medical College have designed, developed and studied a diagnostic staining test they say can determine whether a mole is benign or cancerous relatively quickly and with minimal complexity. » More

CO2 laser compares to surgery for melanoma in situ

London, Ontario — A new study suggests that laser ablation is a viable option to surgical excision for removing the lesion of primary lentigo maligna. » More

FYI ...

41%

 

Percentage of patients with rosacea who say the condition caused them to avoid public contact or social engagements

Source: The National Rosacea Society

LEGAL & REGULATORY

Suit claims Allergan encouraged unsafe use of Botox

Irvine, Calif. — A Las Vegas plastic surgeon is suing Botox-maker Allergan, claiming the Irvine-based company sold the drug in large vials and encouraged physicians to unsafely reuse them, the Los Angeles Times reports. » More

New Job Opportunities

Arizona Skin & Laser

 

Arizona Skin & Laser

Center for Dermatology Care

 

Cynthia Dreyer MD

David A High MD

 

Dermatology Associates of Lancaster

Goldman Dermatology

 

Jordan Medical Consultants

Mark Burnett MD

 

MedDerm Associates

Mosaic Clinic: Dermatology

 

Ochsner Health System

Richard G Glogau

 

Universal Dermatology

 

Confirm your
e-newsletter subscription click here.

To ensure future delivery of email newsletters from Dermatology Times please take a moment to confirm your subscription by clicking here.
Thank you,
Dermatology Times Staff

Tools

Information Technology

Meetings & Events

Practice Management

Resource Centers

Twitter  

Follow us on Twitter

Digital Edition

View current edition

Cover
 
Powered by Modern Medicine Advanstar Medical Communications Group

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.